Karbe and Kerlin have questioned the classification of spongiosis hepatis as a preneoplastic lesion or even a benign neoplasm, designated as spongiotic pericytoma, and have proposed to use the term cystic degeneration for this lesion in rats and fish. However, the reclassification of spongiosis as cystic degeneration is unwarranted for several reasons. In the rat, spongiosis hepatis represents a specific pathomorphologic entity, originating from the perisinusoidal (Ito) cells; it may occur spontaneously in aged animals but its number and size increases significantly after exposure to various (hepato)carcinogens. Comparative morphological, immunohistochemical, and autoradiographic studies in rats exposed to N-nitrosomorpholine revealed that spongiosis hepatis is an integral part of larger proliferative Ito-cell aggregates showing an autonomous, progressive growth. The classification of spongiosis hepatis as a benign neoplasm is based on these findings that endorse and extend previous considerations on the preneoplastic or neoplastic nature of this lesion. Irrespective of the classification of spongiosis hepatis as a benign neoplastic or a preneoplastic lesion, there is compelling evidence for its reliability as a sensitive marker for (hepato)carcinogenic effects in rats and fish. The data collected by Karbe and Kerlin support rather than contradict the reliability of spongiosis hepatis as an effect marker for carcinogens.
In their communication Karbe and Kerlin question the classification of spongiosis hepatis as a putative preneoplastic lesion (1, 2) or even a benign neoplasm (spongiotic pericytoma) in rat (3) , and fish (4) , and propose to use the term cystic degeneration for this lesion. The authors do not present any new data but base their proposal on a review of most, albeit not all, of the available literature. A reclassification of spongiosis hepatis as cystic degeneration, a term previously recommended in some diagnostic guidelines (eg, 5, 6) , is unwarranted for several reasons.
Karbe and Kerlin argue that the morphology of cystic degeneration/spongiosis hepatis "does not have standard neoplastic characteristics." For this reason the term spongiosis hepatis originally coined and introduced into the literature was deliberately descriptive (1) . Nevertheless, a preneoplastic or neoplastic nature of spongiosis hepatis has been considered since its first description, which was exclusively based on morphologic criteria in both rats and fish (1, 2, 4, 7) . Light and electron microscopic observations in these species revealed that spongiosis hepatis represents a specific pathomorphologic entity originating from the perisinusoidal (Ito) cells. This histogenetic relationship has been substantiated by the selective immunohistochemical demonstration of desmin ( Figure 1 ) in both normal perisinusoidal liver cells and cells constituting spongiosis hepatis (3) .
These fibroblast-like cells form the walls of the cavities of the spongiotic lesions that are neither lined by epithelial nor by endothelial cells. Thus, the lesions do not represent true cysts, and might at the most be regarded as pseudocysts. Initially, the considerations on a possible preneoplastic or neoplastic nature of spongiosis hepatis resulted mainly from 4 findings (2, 4): 1) the induction of spongiosis by various hepatocarcinogens; 2) the persistence and progressive development of the lesion even after withdrawal of the inducing chemicals ( Figure 2 ), indicating an autonomous growth behaviour; 3) the progression to more proliferative forms ( Figure 3 ); and 4) the occasional occurence of lesions suggesting transitions into malignant mesenchymal neoplasms ( Figure 4 ). Persistence and progressive development after withdrawal of hepatocarcinogens has also been observed in earlier studies, in which identical morphologic changes were classified as cystic degeneration (8, 9) . The findings that were crucial for the eventual classification of spongiosis hepatis as a benign neoplasm, designated as spongiotic pericytoma, were based on comparative morphological, immunohistochemical, and autoradiographic studies in rats exposed to N -nitrosomorpholine (3). These studies have clearly shown that the progressively growing spongiotic formations are an integral part of larger proliferative aggregates of perisinusoidal (Ito) cells that are positive for desmin, and are lined by the same type of proliferating desmin-positive cells (Figure 1 ). The spongiotic lesions are not only endowed with an increased cell proliferation as demonstrated by an enhanced incorporation of 3 H-thymidine, but also exhibit an increased cell density as determined morphometrically.
Although it is true that spongiotic formations may occur without solid Ito-cell aggregates and vice versa as emphasized by Karbe and Kerlin, this independent appearance is extremely rare, and does not contradict the benign neoplastic nature of each of these lesions. The usual lack of a pronounced compression of the surrounding liver tissue by spongiosis hepatis, stressed by Karbe and Kerlin, also does not rule out a benign neoplasm, particularly since large lesions sometimes do compress the adjacent parenchyma ( Figure 2) . A similar behaviour is well known from another benign liver neoplasm, namely cholangiocellular cystadenoma, most probably reflecting a slow growth of the respective lesions. In case of spongiosis hepatis, however, it has been documented that a more pronounced cell proliferation may emerge within the lesions after long lag periods ( Figure 3 ). In addition, lesions suggesting transitions into malignant mesenchymal neoplasms, designated as perisinusoidal (Ito) cell sarcomas, have been shown to develop, although rarely ( Figure 4 ). I admit that it remains debatable whether these occasional findings (2) are sufficient to establish a histogenetic relationship of spongiosis hepatis to malignant mesenchymal neoplasms, but this uncertainty should not detract from the well-founded classification of spongiosis hepatis as a benign neoplasm. This classification also applies to cases in which spongio-sis hepatis develops without any additional preneoplastic or neoplastic liver lesion.
At least some of the mechanistic considerations by Karbe and Kerlin remain inconclusive. The ambiguity of the term degeneration has already been realized in the early 1950s by Altman (10) . More recently, Majno and Joris (11) stated that "the term degeneration was widely used in pathology before the 1950s when little was known in cell biology; it vaguely implied that some sort of breakdown was involved," but "today we know better," and should restrict the ". . . label degeneration . . . " to ". . . rare instances . . . ". Inside of larger spongiotic lesions cellular damage eventually resulting in the death of single hepatocytes has rarely been observed, but this "degeneration" most likely represents a secondary event.
There is no indication of any remarkable hepatocellular loss preceding the occurrence of spongiosis hepatis. This holds especially true for the occasional development of spongiosis TOXICOLOGIC PATHOLOGY hepatis in untreated aged control animals, and for the induction of the lesion by exposure of rats to low doses of hepatocarcinogens, which do not produce an appreciable amount of toxic necrotic changes in the liver parenchyma (2) . Thus, the idea by Karbe and Kerlin that spongiosis hepatis may represent a secondary/reparative change has no solid basis. The discussion by these authors on the role of the perisinusoidal (Ito) cells in fibrogenesis appears to be somewhat out of place because spongiosis hepatis usually develops without any spatial relationship to liver fibrosis or cirrhosis. Moreover, in contrast to perisinusoidal (Ito) cells that transform into proliferating myofibroblasts expressing α-smooth muscle actin (α-SMA) in addition to desmin during reactive fibrogenesis, the Ito cell aggregates related to spongiosis are not formed by myofibroblasts and are, as a rule, completely negative for α-SMA (3) . The sensitivity of the Ito cells to certain cytokines and growth factors, and the remodelling of the extracellular matrix mentioned as features of fibrogenesis by Karbe and Kerlin might also play a role during neoplastic development. Similarly, the secretion of proteoglycans into the cavities of spongiosis hepatis, which is particularly pronounced in small cavities and gradually decreases with the formation of larger cavities, can hardly be explained as a reparative response as suggested by Karbe and Kerlin, but may indeed be related to neoplastic development as discussed previously (1) (2) (3) . The ambiguous designation as cystic degeneration for a clearly characterized liver lesion should in any case be avoided.
Karbe and Kerlin have pointed out that the Ito-cell tumors described in other mammalian species such as mice, differ in several morphologic features from spongiotic pericytoma of the rat, particularly in their high content of cells with large cytoplasmic fat vacuoles. In contrast to Karbe and Kerlin who mentioned the observation of this type of Ito cell tumor in the rat (text and Table 3 ), I am not aware of any pertinent original publication on this entity. In any case, however, large fat vacuoles visible at the light microscopic level are absent from normal perisinusoidal (Ito) cells in both rats and mice. Hence, the finding that they may be present in mesenchymal neoplasms of the liver is not a strong argument for the origin of these lesions from the Ito cells. In contrast, the demonstration of small fat droplets at the ultrastructural level in some of the cells forming spongiosis hepatis in the rat has provided one of the first arguments for an origin of this lesion from the fat storing Ito cells (1). This inference has been supported by the selective staining of both the normal perisinusoidal (Ito) cells and the cells forming spongiotic pericytoma by desmin (3), and by the close association of both cell types with collagen types III and IV (12) . Thus, in contrast to the opinion expressed by Karbe and Kerlin, the lack of large fat vacuoles in spongiotic pericytoma of the rat can not cast serious doubts on the origin of this lesion from the Ito cells that contain small but not large fat droplets under physiologic conditions.
The statement by Karbe and Kerlin that "most textbooks and all diagnostic guides do not classify cystic degeneration in rats as a preneoplastic or neoplastic lesion, and do not mention spongiotic pericytoma in the rat liver" is misleading. From the six references given in this context, only one refers to a publication which appeared after 1995 when the classification of spongiosis hepatis as a benign neoplastic lesion, designated as spongiotic pericytoma, was proposed for the first time (3). It is true, however, that in this publication all articles and reports on spongiosis hepatis and spongiotic pericytoma having appeared since 1981 were neglected. As to spongiosis hepatis, Goodman et al (5) also disregarded all relevant publications which had appeared until 1994, and recommended the term cystic degeneration for this lesion. Moreover, without providing any scientific argument these authors proposed to diagnose cystic degeneration only when the lesion appears in the extrafocal liver tissue, but not when it develops in preneoplastic hepatic foci or hepatocellular neoplasms.
This diagnostic recommendation has most probably resulted in a considerable underestimation of cystic degeneration/spongiosis hepatis. Similarly, the usual determination of the incidence (ie, the number of animals bearing the lesion) instead of the number and size of the spongiotic lesions (area fraction of liver tissue occupied by the lesion) per animal seriously hampers the detection of significant differences between animals exposed to carcinogens and untreated controls, as exemplified for preneoplastic hepatocellular foci recently (13) . In addition to the chapters in textbooks and diagnostic guides quoted by Karbe and Kerlin, this author has included spongiosis hepatis and, after 1995, also spongiotic pericytoma in contributions to three other widely distributed textbooks (14) (15) (16) .
The original assumption that spongiosis hepatis results from carcinogen-induced changes of the perisinusoidal liver cells (1) has been substantiated by the observation that this lesion frequently develops after exposure of rats (2) and fish (4) to various chemical hepatocarcinogens. Hence, irrespective of its classification as a benign neoplastic, a preneoplastic or even a nonneoplastic lesion spongiosis hepatis has been considered a very sensitive marker for hepatocarcinogenic effects (2, 12) . The argument by Karbe and Kerlin that spongiosis hepatis does not indicate genotoxicity distracts from the striking association of the lesion with carcinogenic effects. It has actually never been postulated that spongiosis hepatis might serve as an indicator of genotoxicity, particularly since it has been known for some time that carcinogenicity is by no means regularly related to genotoxicity (as determined by the standard test systems to which Karbe and Kerlin refer).
In addition to their confusing argument on genotoxicity, Karbe and Kerlin deduce from the data collected in their review that ". . . the cause of cystic degeneration in the liver is not directly related to a . . . carcinogenic potential of a compound . . . ". However, with two doubtful exceptions all the data presented strongly support the notion that spongiosis hepatis is a reliable indicator of a (hepato)carcinogenic potential of the inducing compound. In addition to several well known hepatocarcinogens (Nnitrosomorpholine, N -nitrosodiethylamine, nitrosopyrrolidine, N-2-fluorenylacetamide) reported previously (12) , all 9 chemicals inducing spongiosis hepatis taken from the NTP database were carcinogens, 7 producing hepatocellular (in one case also cholangiocellular) neoplasms, and 2 eliciting neoplasms in other tissues. Even from the two latter compounds, pentachlorophenol and malonaldehyde, which did not induce liver neoplasms under the conditions of the chronic carcinogenesis bioassay, at least pentachlorophenol had effects on the liver tissue which have been considered Vol. 31, No. 5, 2003 SPONGIOSIS HEPATIS/SPONGIOTIC PERICYTOMA 569 indicators of a hepatocarcinogenic potential. In the case of pentachlorophenol, such indicators are an increased incidence of centrilobular hepatocellular hypertrophy (17, 18) , and basophilic preneoplastic hepatocelluar foci (17, 19) which were not mentioned in the review by Karbe and Kerlin but are evident from the NTP report TR-483. In the case of malonaldehyde, bile duct hyperplasia plus bile duct fibrosis have been observed. These changes may correspond to cholangiofibrosis, which has been well known as a precusor of cholangiocellular neoplasms. From the three remaining chemicals inducing spongiosis which were included in the review, the peroxisome proliferator di(2-ethylhexyl)phthalate (DEHP) is not only a hepatocarcinogen but also produces different types of extrahepatic tumors in the rat, including exocrine and endocrine pancreatic adenomas.
Finally, two chemicals are listed in the review that were not applied orally but by inhalation (dimethylacetamide) or by skin painting (KBR 3023). These are the only examples of chemicals quoted which induced spongiosis hepatis, while no hepatocellular or cholangiocellular neoplasms or neoplasms in extrahepatic tissues were observed under the testing conditions published. However, the critical carcinogen dose to produce these neoplasms may not have been attained in the liver or other target tissues by the routes of application used in these experimental settings. In line with this assumption, an unpublished report on chronic oral toxicity/carcinogenicity studies in rats is mentioned in ref 20 for the statement that the liver appeared to be the primary target organ exposed to dimethylacetamide. Moreover, according to the results summarized by Karbe and Kerlin, even inhalation of dimethylacetamide induced bile duct hyperplasia and, particularly, peliosis hepatis, which has been repeatedly linked with the evolution of benign and malignant hemangioendotheliomas in rat liver (21, 22) . According to the original publication, ". . . the testing process of KBR 3023 was not typical for a pesticide in that . . . the entire data package was developed via the dermal route of administration. . . . " (23) . Nevertheless, as mentioned in a footnote to the data presented in the review, oral exposure to KBR 3023 for 90 days only resulted in compound-related effects in the liver and kidney, including an increase in liver weight (23) , which is a frequent finding related to nongenotoxic mechanisms of hepatocarcinogenesis (24) .
Three recent reports that were not considerd in the review endorse the notion that spongiosis hepatis is an indicator of hepatocarcinogenicity. Inhalation of methylethylketoxime resulted in an increased incidence of spongiosis hepatis, preneoplastic foci of altered hepatocytes, hepatocellular adenomas and carcinomas in male rats (25) . An "increased incidence and/or severity" of spongiosis hepatis has also been described in rats exposed to propylene glycol monomethyl ether by inhalation (26) . Spongiosis was associated with preneoplastic hepatocellular foci, being located in both the intrafocal and the extrafocal liver tissue. The significance of preneoplastic foci of altered hepatocytes for the identification of hepatocarcinogenic potential has been emphasized in one of the last issues of this journal (13, 18, 19) . In addition, exposure to propylene glycol monomethyl ether resulted in an increased incidence of renal cell adenomas (26) . Finally, a compound closely related to DHEP, namely di(isononyl)phthalate (DINP), has been shown to induce an increased incidence of both spongiosis hepatis and hepatocellular neoplasms in male rats exposed to high oral doses (27) .
It is evident from these data that there is virtually no chemical compound inducing spongiosis hepatis in the rat without causing additional effects on the liver or other tissues suggesting (hepato)carcinogenicity. Karbe and Kerlin mention that ". . . noncarcinogens can cause an increased incidence of this lesion in fish . . . " referring to a report by Boorman et al (6) . Close inspection of this report reveals, however, that this quotation is not valid. Bunton who is quoted in this context (6) for having raised critical questions concerning the neoplastic nature of spongiosis hepatis did find the lesion after exposure of fish to the hepatocarcinogen N -nitrosodiethylamine (28) . Hawkins and Wolfe are quoted for unpublished observations, but not a single noncarcinogenic chemical compound inducing spongiosis hepatis in fish is named in the report by Boorman et al (6) .
All findings discussed indicate that spongiosis hepatis is not a degenerative but a proliferative lesion with an autonomous, progressive growth behaviour. Even if an independent verification of the proposed neoplastic nature (spongiotic pericytoma) of the lesion by other laboratories was desirable (6) , there is little, if any, doubt that spongiosis hepatis is a reliable marker for hepatocarcinogenic effects, and should not be misclassified as cystic degeneration. Karbe and Kerlin are afraid that an increase in the incidence of this lesion by exposure of rats to a chemical may result in major concern as long as it is regarded as a neoplasm, implying a potential for human carcinogenesis. However, this conclusion is indeed justified irrespective of the classification of spongiosis hepatis as a benign neoplastic or a preneoplastic lesion. In my opinion, this inference would even be legitimate if spongiosis hepatis represented a nonneoplastic lesion. As stated by Tomatis (29) in a recent discussion on the role of carcinogenesis bioassays in the protection of public health, "in the absence of absolute certainty, rarely if ever reached in biology, it is essential to adopt an attitude of responsible caution, in line with the principles of primary prevention, the only one that prevents unlimited experimentation on the entire human species."
